With Exchanges Comes Uptick in Brand-Name Drug Prescriptions for Chronic Conditions

Patients on the new insurance exchanges are more likely to have received brand name drugs for their chronic conditions, according to a report from The Washington Post.

Advertisement

Numbers from Express Scripts on pharmacy benefits indicated exchange enrollees in January and February received specialty medications more than 1 percent of the time for conditions such as cancer, hepatitis C and HIV. That number is somewhat less than 1 percent for commercial health plans. These prescriptions account for less than 1 percent of prescriptions and nearly one-quarter of spending on pharmaceuticals, according to the report.

Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!

While the trend may be worrying, it is not yet a major cause for concern, according to the report, as health plans have only analyzed very early data on their new enrollees.

More Articles on Infection Control & Clinical Quality:

6 Findings on CAUTI Burden and Outcomes

Infant Age Affects Post-Op Infection Risk Reduction Procedures

S.C. Hospitals Aim for Checklist Use in Every OR, Expect $28M in Savings

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.